Role of nitric oxide and tumor necrosis factor on lung injury caused by ischemia/reperfusion of the lower extremities

Purpose: Acute aortic occlusion with subsequent ischemia/reperfusion (I/R) of the lower extremities is known to predispose to lung injury. The pathophysiologic mechanisms of this injury are not clear. In the present study, we studied the role of tumor necrosis factor (TNF) and nitric oxide (NO) in l...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of vascular surgery 1997-10, Vol.26 (4), p.647-656
Hauptverfasser: Tassiopoulos, Apostolos K., Carlin, Robert E., Gao, Yuqi, Pedoto, Alessia, Finck, Christine M., Landas, Steve K., Tice, Diane G., Marx, William, Hakim, Tawfic S., McGraw, Daniel J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 656
container_issue 4
container_start_page 647
container_title Journal of vascular surgery
container_volume 26
creator Tassiopoulos, Apostolos K.
Carlin, Robert E.
Gao, Yuqi
Pedoto, Alessia
Finck, Christine M.
Landas, Steve K.
Tice, Diane G.
Marx, William
Hakim, Tawfic S.
McGraw, Daniel J.
description Purpose: Acute aortic occlusion with subsequent ischemia/reperfusion (I/R) of the lower extremities is known to predispose to lung injury. The pathophysiologic mechanisms of this injury are not clear. In the present study, we studied the role of tumor necrosis factor (TNF) and nitric oxide (NO) in lung injury caused by lower extremity I/R. Methods: A rat model in which the infrarenal aorta was cross-clamped for 3 hours followed by 1 hour of reperfusion was used. The rats were randomized into five groups: group 1, aorta exposed but not clamped; group 2, aorta clamped for 3 hours, followed by 1 hour of reperfusion; group 3, 1 mg/kg dexamethasone administered before the aorta was clamped; group 4, 25 mg aminoguanidine, a specific inducible NO synthase (iNOS) inhibitor, administered before the aorta was clamped; and group 5, 2 mg/kg TNF bp, a PEG-ylated dimeric form of the high-affinity p55 TNF receptor I (R I), administered before the aorta was clamped. NO concentration in the exhaled gas (ENO) was measured, as an index of NO production by the lung, in 30 minute intervals during I/R. Serial arterial blood samples for TNF assay were obtained during the course of the experiment. At the end of the experiment, the lungs were removed and histologically examined for evidence of injury. Results: ENO in group 2 increased from 0.7 ± 0.3 ppb at baseline to 54.3 ± 7.5 ppb at the end of ischemia and remained stable during reperfusion (54.6 ± 8.5 ppb at the end of reperfusion). ENO production was blocked by aminoguanidine, by dexamethasone, and by TNF bp given before aortic occlusion. Serum TNF in groups 2, 3, and 4 increased rapidly during early ischemia, reaching its peak value 60 minutes after occlusion of the aorta, then gradually declined to baseline levels at the end of ischemia, and remained low during reperfusion. TNF bp decreased serum TNF concentration significantly when it was given before aortic occlusion. Histologic examination of the lungs at the end of the experiment revealed that aminoguanidine, dexamethasone, and TNF bp had a protective effect on the lungs. Conclusions: Serum TNF increases rapidly during lower extremity ischemia and causes increased production of NO from the lung by upregulating iNOS. Increased NO is associated with more severe lung injury, and iNOS blockade has beneficial effects on the lung. TNF blockade before ischemia decreases NO production by the lung and attenuates lung injury. ENO can be used as an early marker of lung injury caus
doi_str_mv 10.1016/S0741-5214(97)70065-X
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79391583</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S074152149770065X</els_id><sourcerecordid>79391583</sourcerecordid><originalsourceid>FETCH-LOGICAL-c436t-d3bb698fe444a564e7be1f9646c57ebcb6c40751314530f1baec5f5a77f045de3</originalsourceid><addsrcrecordid>eNqFkMlqHDEQQIVxsCdOPsGggzHJoWNpWsvoZILJBoZAFvBNqNUlW6ZbGmtJPH8fjWeYa05FUa-2h9A5JR8ooeLqJ5GMdnxJ2Tsl30tCBO_ujtCCEiU7sSLqGC0OyCl6nfMjIZTylTxBJ6rnkgm5QPVHnABHh4MvyVscn_0I2IQRlzrHhAPYFLPP2BlbWh4Dnmq4xz481rTB1tQMIx422Gf7ALM3VwnWkFzNvqFtbnkAPMW_kDA8l9SI4iG_Qa-cmTK83ccz9Pvzp183X7vb71--3Xy87SzrRenGfhiEWjlgjBkuGMgBqFOCCcslDHYQlhHJaU8Z74mjgwHLHTdSOsL4CP0ZutzNXaf4VCEXPbc7YZpMgFizlqpXzUjfQL4Dt9_mBE6vk59N2mhK9Fa3ftGtty61kvpFt75rfef7BXWYYTx07f22-sW-brI1k0smWJ8P2JJwtiS0Ydc7DJqMPx6SztZDsDD6BLboMfr_HPIP8uCeqQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79391583</pqid></control><display><type>article</type><title>Role of nitric oxide and tumor necrosis factor on lung injury caused by ischemia/reperfusion of the lower extremities</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Tassiopoulos, Apostolos K. ; Carlin, Robert E. ; Gao, Yuqi ; Pedoto, Alessia ; Finck, Christine M. ; Landas, Steve K. ; Tice, Diane G. ; Marx, William ; Hakim, Tawfic S. ; McGraw, Daniel J.</creator><creatorcontrib>Tassiopoulos, Apostolos K. ; Carlin, Robert E. ; Gao, Yuqi ; Pedoto, Alessia ; Finck, Christine M. ; Landas, Steve K. ; Tice, Diane G. ; Marx, William ; Hakim, Tawfic S. ; McGraw, Daniel J. ; From the Department of Surgery and the Department of Pathology, State University of New York Health Science Center</creatorcontrib><description>Purpose: Acute aortic occlusion with subsequent ischemia/reperfusion (I/R) of the lower extremities is known to predispose to lung injury. The pathophysiologic mechanisms of this injury are not clear. In the present study, we studied the role of tumor necrosis factor (TNF) and nitric oxide (NO) in lung injury caused by lower extremity I/R. Methods: A rat model in which the infrarenal aorta was cross-clamped for 3 hours followed by 1 hour of reperfusion was used. The rats were randomized into five groups: group 1, aorta exposed but not clamped; group 2, aorta clamped for 3 hours, followed by 1 hour of reperfusion; group 3, 1 mg/kg dexamethasone administered before the aorta was clamped; group 4, 25 mg aminoguanidine, a specific inducible NO synthase (iNOS) inhibitor, administered before the aorta was clamped; and group 5, 2 mg/kg TNF bp, a PEG-ylated dimeric form of the high-affinity p55 TNF receptor I (R I), administered before the aorta was clamped. NO concentration in the exhaled gas (ENO) was measured, as an index of NO production by the lung, in 30 minute intervals during I/R. Serial arterial blood samples for TNF assay were obtained during the course of the experiment. At the end of the experiment, the lungs were removed and histologically examined for evidence of injury. Results: ENO in group 2 increased from 0.7 ± 0.3 ppb at baseline to 54.3 ± 7.5 ppb at the end of ischemia and remained stable during reperfusion (54.6 ± 8.5 ppb at the end of reperfusion). ENO production was blocked by aminoguanidine, by dexamethasone, and by TNF bp given before aortic occlusion. Serum TNF in groups 2, 3, and 4 increased rapidly during early ischemia, reaching its peak value 60 minutes after occlusion of the aorta, then gradually declined to baseline levels at the end of ischemia, and remained low during reperfusion. TNF bp decreased serum TNF concentration significantly when it was given before aortic occlusion. Histologic examination of the lungs at the end of the experiment revealed that aminoguanidine, dexamethasone, and TNF bp had a protective effect on the lungs. Conclusions: Serum TNF increases rapidly during lower extremity ischemia and causes increased production of NO from the lung by upregulating iNOS. Increased NO is associated with more severe lung injury, and iNOS blockade has beneficial effects on the lung. TNF blockade before ischemia decreases NO production by the lung and attenuates lung injury. ENO can be used as an early marker of lung injury caused by lower extremity I/R. (J Vasc Surg 1997;26:647-56.)</description><identifier>ISSN: 0741-5214</identifier><identifier>EISSN: 1097-6809</identifier><identifier>DOI: 10.1016/S0741-5214(97)70065-X</identifier><identifier>PMID: 9357467</identifier><identifier>CODEN: JVSUES</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Animals ; Aorta, Abdominal ; Biological and medical sciences ; Blood and lymphatic vessels ; Cardiology. Vascular system ; Constriction ; Dexamethasone - pharmacology ; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous ; Enzyme Inhibitors - pharmacology ; Guanidines - pharmacology ; Hindlimb - blood supply ; Lung - blood supply ; Lung - metabolism ; Lung - pathology ; Male ; Medical sciences ; Nitric Oxide - metabolism ; Nitric Oxide - physiology ; Nitric Oxide Synthase - antagonists &amp; inhibitors ; Rats ; Rats, Sprague-Dawley ; Reperfusion Injury - metabolism ; Reperfusion Injury - pathology ; Reperfusion Injury - physiopathology ; Tumor Necrosis Factor-alpha - analysis ; Tumor Necrosis Factor-alpha - physiology</subject><ispartof>Journal of vascular surgery, 1997-10, Vol.26 (4), p.647-656</ispartof><rights>1997 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c436t-d3bb698fe444a564e7be1f9646c57ebcb6c40751314530f1baec5f5a77f045de3</citedby><cites>FETCH-LOGICAL-c436t-d3bb698fe444a564e7be1f9646c57ebcb6c40751314530f1baec5f5a77f045de3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0741-5214(97)70065-X$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2054201$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9357467$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tassiopoulos, Apostolos K.</creatorcontrib><creatorcontrib>Carlin, Robert E.</creatorcontrib><creatorcontrib>Gao, Yuqi</creatorcontrib><creatorcontrib>Pedoto, Alessia</creatorcontrib><creatorcontrib>Finck, Christine M.</creatorcontrib><creatorcontrib>Landas, Steve K.</creatorcontrib><creatorcontrib>Tice, Diane G.</creatorcontrib><creatorcontrib>Marx, William</creatorcontrib><creatorcontrib>Hakim, Tawfic S.</creatorcontrib><creatorcontrib>McGraw, Daniel J.</creatorcontrib><creatorcontrib>From the Department of Surgery and the Department of Pathology, State University of New York Health Science Center</creatorcontrib><title>Role of nitric oxide and tumor necrosis factor on lung injury caused by ischemia/reperfusion of the lower extremities</title><title>Journal of vascular surgery</title><addtitle>J Vasc Surg</addtitle><description>Purpose: Acute aortic occlusion with subsequent ischemia/reperfusion (I/R) of the lower extremities is known to predispose to lung injury. The pathophysiologic mechanisms of this injury are not clear. In the present study, we studied the role of tumor necrosis factor (TNF) and nitric oxide (NO) in lung injury caused by lower extremity I/R. Methods: A rat model in which the infrarenal aorta was cross-clamped for 3 hours followed by 1 hour of reperfusion was used. The rats were randomized into five groups: group 1, aorta exposed but not clamped; group 2, aorta clamped for 3 hours, followed by 1 hour of reperfusion; group 3, 1 mg/kg dexamethasone administered before the aorta was clamped; group 4, 25 mg aminoguanidine, a specific inducible NO synthase (iNOS) inhibitor, administered before the aorta was clamped; and group 5, 2 mg/kg TNF bp, a PEG-ylated dimeric form of the high-affinity p55 TNF receptor I (R I), administered before the aorta was clamped. NO concentration in the exhaled gas (ENO) was measured, as an index of NO production by the lung, in 30 minute intervals during I/R. Serial arterial blood samples for TNF assay were obtained during the course of the experiment. At the end of the experiment, the lungs were removed and histologically examined for evidence of injury. Results: ENO in group 2 increased from 0.7 ± 0.3 ppb at baseline to 54.3 ± 7.5 ppb at the end of ischemia and remained stable during reperfusion (54.6 ± 8.5 ppb at the end of reperfusion). ENO production was blocked by aminoguanidine, by dexamethasone, and by TNF bp given before aortic occlusion. Serum TNF in groups 2, 3, and 4 increased rapidly during early ischemia, reaching its peak value 60 minutes after occlusion of the aorta, then gradually declined to baseline levels at the end of ischemia, and remained low during reperfusion. TNF bp decreased serum TNF concentration significantly when it was given before aortic occlusion. Histologic examination of the lungs at the end of the experiment revealed that aminoguanidine, dexamethasone, and TNF bp had a protective effect on the lungs. Conclusions: Serum TNF increases rapidly during lower extremity ischemia and causes increased production of NO from the lung by upregulating iNOS. Increased NO is associated with more severe lung injury, and iNOS blockade has beneficial effects on the lung. TNF blockade before ischemia decreases NO production by the lung and attenuates lung injury. ENO can be used as an early marker of lung injury caused by lower extremity I/R. (J Vasc Surg 1997;26:647-56.)</description><subject>Animals</subject><subject>Aorta, Abdominal</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiology. Vascular system</subject><subject>Constriction</subject><subject>Dexamethasone - pharmacology</subject><subject>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Guanidines - pharmacology</subject><subject>Hindlimb - blood supply</subject><subject>Lung - blood supply</subject><subject>Lung - metabolism</subject><subject>Lung - pathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Nitric Oxide - metabolism</subject><subject>Nitric Oxide - physiology</subject><subject>Nitric Oxide Synthase - antagonists &amp; inhibitors</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Reperfusion Injury - metabolism</subject><subject>Reperfusion Injury - pathology</subject><subject>Reperfusion Injury - physiopathology</subject><subject>Tumor Necrosis Factor-alpha - analysis</subject><subject>Tumor Necrosis Factor-alpha - physiology</subject><issn>0741-5214</issn><issn>1097-6809</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMlqHDEQQIVxsCdOPsGggzHJoWNpWsvoZILJBoZAFvBNqNUlW6ZbGmtJPH8fjWeYa05FUa-2h9A5JR8ooeLqJ5GMdnxJ2Tsl30tCBO_ujtCCEiU7sSLqGC0OyCl6nfMjIZTylTxBJ6rnkgm5QPVHnABHh4MvyVscn_0I2IQRlzrHhAPYFLPP2BlbWh4Dnmq4xz481rTB1tQMIx422Gf7ALM3VwnWkFzNvqFtbnkAPMW_kDA8l9SI4iG_Qa-cmTK83ccz9Pvzp183X7vb71--3Xy87SzrRenGfhiEWjlgjBkuGMgBqFOCCcslDHYQlhHJaU8Z74mjgwHLHTdSOsL4CP0ZutzNXaf4VCEXPbc7YZpMgFizlqpXzUjfQL4Dt9_mBE6vk59N2mhK9Fa3ftGtty61kvpFt75rfef7BXWYYTx07f22-sW-brI1k0smWJ8P2JJwtiS0Ydc7DJqMPx6SztZDsDD6BLboMfr_HPIP8uCeqQ</recordid><startdate>19971001</startdate><enddate>19971001</enddate><creator>Tassiopoulos, Apostolos K.</creator><creator>Carlin, Robert E.</creator><creator>Gao, Yuqi</creator><creator>Pedoto, Alessia</creator><creator>Finck, Christine M.</creator><creator>Landas, Steve K.</creator><creator>Tice, Diane G.</creator><creator>Marx, William</creator><creator>Hakim, Tawfic S.</creator><creator>McGraw, Daniel J.</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19971001</creationdate><title>Role of nitric oxide and tumor necrosis factor on lung injury caused by ischemia/reperfusion of the lower extremities</title><author>Tassiopoulos, Apostolos K. ; Carlin, Robert E. ; Gao, Yuqi ; Pedoto, Alessia ; Finck, Christine M. ; Landas, Steve K. ; Tice, Diane G. ; Marx, William ; Hakim, Tawfic S. ; McGraw, Daniel J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c436t-d3bb698fe444a564e7be1f9646c57ebcb6c40751314530f1baec5f5a77f045de3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Animals</topic><topic>Aorta, Abdominal</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiology. Vascular system</topic><topic>Constriction</topic><topic>Dexamethasone - pharmacology</topic><topic>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Guanidines - pharmacology</topic><topic>Hindlimb - blood supply</topic><topic>Lung - blood supply</topic><topic>Lung - metabolism</topic><topic>Lung - pathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Nitric Oxide - metabolism</topic><topic>Nitric Oxide - physiology</topic><topic>Nitric Oxide Synthase - antagonists &amp; inhibitors</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Reperfusion Injury - metabolism</topic><topic>Reperfusion Injury - pathology</topic><topic>Reperfusion Injury - physiopathology</topic><topic>Tumor Necrosis Factor-alpha - analysis</topic><topic>Tumor Necrosis Factor-alpha - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tassiopoulos, Apostolos K.</creatorcontrib><creatorcontrib>Carlin, Robert E.</creatorcontrib><creatorcontrib>Gao, Yuqi</creatorcontrib><creatorcontrib>Pedoto, Alessia</creatorcontrib><creatorcontrib>Finck, Christine M.</creatorcontrib><creatorcontrib>Landas, Steve K.</creatorcontrib><creatorcontrib>Tice, Diane G.</creatorcontrib><creatorcontrib>Marx, William</creatorcontrib><creatorcontrib>Hakim, Tawfic S.</creatorcontrib><creatorcontrib>McGraw, Daniel J.</creatorcontrib><creatorcontrib>From the Department of Surgery and the Department of Pathology, State University of New York Health Science Center</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of vascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tassiopoulos, Apostolos K.</au><au>Carlin, Robert E.</au><au>Gao, Yuqi</au><au>Pedoto, Alessia</au><au>Finck, Christine M.</au><au>Landas, Steve K.</au><au>Tice, Diane G.</au><au>Marx, William</au><au>Hakim, Tawfic S.</au><au>McGraw, Daniel J.</au><aucorp>From the Department of Surgery and the Department of Pathology, State University of New York Health Science Center</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of nitric oxide and tumor necrosis factor on lung injury caused by ischemia/reperfusion of the lower extremities</atitle><jtitle>Journal of vascular surgery</jtitle><addtitle>J Vasc Surg</addtitle><date>1997-10-01</date><risdate>1997</risdate><volume>26</volume><issue>4</issue><spage>647</spage><epage>656</epage><pages>647-656</pages><issn>0741-5214</issn><eissn>1097-6809</eissn><coden>JVSUES</coden><abstract>Purpose: Acute aortic occlusion with subsequent ischemia/reperfusion (I/R) of the lower extremities is known to predispose to lung injury. The pathophysiologic mechanisms of this injury are not clear. In the present study, we studied the role of tumor necrosis factor (TNF) and nitric oxide (NO) in lung injury caused by lower extremity I/R. Methods: A rat model in which the infrarenal aorta was cross-clamped for 3 hours followed by 1 hour of reperfusion was used. The rats were randomized into five groups: group 1, aorta exposed but not clamped; group 2, aorta clamped for 3 hours, followed by 1 hour of reperfusion; group 3, 1 mg/kg dexamethasone administered before the aorta was clamped; group 4, 25 mg aminoguanidine, a specific inducible NO synthase (iNOS) inhibitor, administered before the aorta was clamped; and group 5, 2 mg/kg TNF bp, a PEG-ylated dimeric form of the high-affinity p55 TNF receptor I (R I), administered before the aorta was clamped. NO concentration in the exhaled gas (ENO) was measured, as an index of NO production by the lung, in 30 minute intervals during I/R. Serial arterial blood samples for TNF assay were obtained during the course of the experiment. At the end of the experiment, the lungs were removed and histologically examined for evidence of injury. Results: ENO in group 2 increased from 0.7 ± 0.3 ppb at baseline to 54.3 ± 7.5 ppb at the end of ischemia and remained stable during reperfusion (54.6 ± 8.5 ppb at the end of reperfusion). ENO production was blocked by aminoguanidine, by dexamethasone, and by TNF bp given before aortic occlusion. Serum TNF in groups 2, 3, and 4 increased rapidly during early ischemia, reaching its peak value 60 minutes after occlusion of the aorta, then gradually declined to baseline levels at the end of ischemia, and remained low during reperfusion. TNF bp decreased serum TNF concentration significantly when it was given before aortic occlusion. Histologic examination of the lungs at the end of the experiment revealed that aminoguanidine, dexamethasone, and TNF bp had a protective effect on the lungs. Conclusions: Serum TNF increases rapidly during lower extremity ischemia and causes increased production of NO from the lung by upregulating iNOS. Increased NO is associated with more severe lung injury, and iNOS blockade has beneficial effects on the lung. TNF blockade before ischemia decreases NO production by the lung and attenuates lung injury. ENO can be used as an early marker of lung injury caused by lower extremity I/R. (J Vasc Surg 1997;26:647-56.)</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>9357467</pmid><doi>10.1016/S0741-5214(97)70065-X</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0741-5214
ispartof Journal of vascular surgery, 1997-10, Vol.26 (4), p.647-656
issn 0741-5214
1097-6809
language eng
recordid cdi_proquest_miscellaneous_79391583
source MEDLINE; Access via ScienceDirect (Elsevier); EZB-FREE-00999 freely available EZB journals
subjects Animals
Aorta, Abdominal
Biological and medical sciences
Blood and lymphatic vessels
Cardiology. Vascular system
Constriction
Dexamethasone - pharmacology
Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous
Enzyme Inhibitors - pharmacology
Guanidines - pharmacology
Hindlimb - blood supply
Lung - blood supply
Lung - metabolism
Lung - pathology
Male
Medical sciences
Nitric Oxide - metabolism
Nitric Oxide - physiology
Nitric Oxide Synthase - antagonists & inhibitors
Rats
Rats, Sprague-Dawley
Reperfusion Injury - metabolism
Reperfusion Injury - pathology
Reperfusion Injury - physiopathology
Tumor Necrosis Factor-alpha - analysis
Tumor Necrosis Factor-alpha - physiology
title Role of nitric oxide and tumor necrosis factor on lung injury caused by ischemia/reperfusion of the lower extremities
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T06%3A33%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20nitric%20oxide%20and%20tumor%20necrosis%20factor%20on%20lung%20injury%20caused%20by%20ischemia/reperfusion%20of%20the%20lower%20extremities&rft.jtitle=Journal%20of%20vascular%20surgery&rft.au=Tassiopoulos,%20Apostolos%20K.&rft.aucorp=From%20the%20Department%20of%20Surgery%20and%20the%20Department%20of%20Pathology,%20State%20University%20of%20New%20York%20Health%20Science%20Center&rft.date=1997-10-01&rft.volume=26&rft.issue=4&rft.spage=647&rft.epage=656&rft.pages=647-656&rft.issn=0741-5214&rft.eissn=1097-6809&rft.coden=JVSUES&rft_id=info:doi/10.1016/S0741-5214(97)70065-X&rft_dat=%3Cproquest_cross%3E79391583%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79391583&rft_id=info:pmid/9357467&rft_els_id=S074152149770065X&rfr_iscdi=true